News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
King Rachel K.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| King Rachel K. (Director) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Granted 6,667 shares
@ $1.5, valued at
$10k
|
|
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/30/2020 |
4
| King Rachel K. (President, CEO) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Sold 84,176 shares
@ $3.91, valued at
$329.1k
Exercised 130,821 options to buy
@ $1.12, valued at
$146.5k
|
|
| 06/26/2020 |
4
| King Rachel K. (Director) has filed a Form 4 on NOVAVAX INC|
Txns:
| Granted 6,900 options to buy
@ $83.54, valued at
$576.4k
Granted 3,450 restricted stock units
@ $0 |
|
| 01/24/2020 |
4
| King Rachel K. (President, CEO) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Granted 349,000 options to buy
@ $4.72, valued at
$1.6M
|
|
| 12/16/2019 |
4
| King Rachel K. (Director) has filed a Form 4 on NOVAVAX INC|
Txns:
| Granted 18,000 options to buy
@ $3.99, valued at
$71.8k
|
|
| 08/07/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/28/2019 |
4
| King Rachel K. (Director) has filed a Form 4 on NOVAVAX INC|
Txns:
| Bought 42,000 shares
@ $0.5298, valued at
$22.3k
Bought 22,000 shares
@ $0.5298, valued at
$11.7k
Bought 22,000 shares
@ $0.5298, valued at
$11.7k
|
|
| 01/22/2019 |
4
| King Rachel K. (President, CEO) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Granted 265,000 options to buy
@ $10.59, valued at
$2.8M
|
|
| 11/02/2018 |
4
| King Rachel K. (Director) has filed a Form 4 on NOVAVAX INC|
Txns:
| Granted 160,000 options to buy
@ $1.76, valued at
$281.6k
|
|
| 01/12/2018 |
4
| King Rachel K. (President, CEO) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Granted 175,000 options to buy
@ $20.03, valued at
$3.5M
|
|
| 01/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|